Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.47 Analyst target: $20.55 Upside: 142.62%
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.